| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/12/2014 | CN103582495A Psychic energizer agent and psychic energizer composition |
| 02/12/2014 | CN103582485A Oligosaccharide composition for treating acute respiratory tract infections |
| 02/12/2014 | CN103582481A Use of A2B adenosine receptor antagonists for treating heart failure and arrhythmia in post-myocardial infarction patients |
| 02/12/2014 | CN103582477A Combination comprising umeclidinium and a corticosteroid |
| 02/12/2014 | CN103566377A Targeted immunotherapy for cancer |
| 02/12/2014 | CN103566373A Drug composition containing cholesterol absorption inhibitor and HMG-CoA reductase inhibitor, preparation method and use thereof |
| 02/12/2014 | CN103566372A Pharmaceutical composition for lowering blood pressure |
| 02/12/2014 | CN103566371A 抗微生物的物理方法 Physical methods antimicrobial |
| 02/12/2014 | CN103565741A Glucocorticoid ophthalmic water suspension having redispersibility |
| 02/12/2014 | CN103565738A Rapidly-dispersed water-mixed suspension medicine used for eyes |
| 02/12/2014 | CN103565737A Compound glucocorticoid eye drops |
| 02/12/2014 | CN103125933B Liver and gallbladder calculus removing product |
| 02/12/2014 | CN101829328B Drug for treating amphetamine-type exhilarant dependence syndrome and amphetamine-type exhilarant and opioid mixed dependence syndrome |
| 02/12/2014 | CN101646459B Chronic rejection inhibitor |
| 02/11/2014 | US8648174 Ucp4 |
| 02/11/2014 | US8648095 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor |
| 02/11/2014 | US8648056 Composition for local anesthesia |
| 02/11/2014 | US8648055 Virucidal properties of various forms of sophorolipids |
| 02/11/2014 | US8648054 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| 02/11/2014 | US8648051 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| 02/11/2014 | US8648047 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 02/11/2014 | US8647603 Devices and methods for the treatment of cancer |
| 02/11/2014 | CA2617312C Noninvasive measurement of chemical substances |
| 02/11/2014 | CA2493806C Aqueous iron carbohydrate complexes, their production and medicaments containing them |
| 02/11/2014 | CA2471432C Nonhuman model animal lacking the ability to control lymphocyte migration |
| 02/11/2014 | CA2466632C Injectable depot compositions and uses thereof |
| 02/11/2014 | CA2421751C Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 02/06/2014 | WO2014022841A1 Cyclodextrin for the treatment of lysosomal storage diseases |
| 02/06/2014 | WO2014021804A1 A method for increasing meat and milk production |
| 02/06/2014 | WO2014021803A1 Use of olanzapine in animals |
| 02/06/2014 | WO2014021802A1 Use of fluoxetine for increasing meat and milk production |
| 02/06/2014 | WO2014021801A1 Use of fluoxetine in animals |
| 02/06/2014 | WO2014021408A1 Method for treating cancer by anticancer agent co-administration |
| 02/06/2014 | WO2014021306A1 Medicine against gastroesophageal reflux disease |
| 02/06/2014 | WO2014020344A1 Compounds and their effects on appetite control and insulin sensitivity |
| 02/06/2014 | WO2014020043A1 Combinations for the treatment of cancer |
| 02/06/2014 | WO2014020041A1 Combinations for the treatment of cancer |
| 02/06/2014 | WO2014019452A1 Physical antimicrobial method |
| 02/06/2014 | US20140039059 Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes |
| 02/06/2014 | US20140039054 Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss |
| 02/06/2014 | US20140039053 Therapeutic agent for diastolic congestive heart failure |
| 02/06/2014 | US20140039043 Pharmaceutical compositions comprising cannabigerol |
| 02/06/2014 | US20140039039 Organic compositions to treat hsf1-related diseases |
| 02/06/2014 | US20140039029 Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters |
| 02/06/2014 | US20140039022 Manufacture, compositions and uses of coagulation factor viia modulator |
| 02/06/2014 | US20140039019 Methods of Using Ryanodine Antagonists in Treating Neural Injury |
| 02/06/2014 | US20140039012 Compounds Having CRTH2 Antagonist Activity |
| 02/06/2014 | US20140039009 Compounds for inflammation and immune-related uses |
| 02/06/2014 | US20140039007 Compositions and methods for modulating farnesoid x receptors |
| 02/06/2014 | US20140039004 Method of treating of gastroesophageal reflux disease |
| 02/06/2014 | US20140038991 Protein Kinase Inhibitors |
| 02/06/2014 | US20140038990 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 02/06/2014 | US20140038989 Tetrahydropyrazolo [1,5-a] pyrimidine as anti-tuberculosis compounds |
| 02/06/2014 | US20140038988 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd |
| 02/06/2014 | US20140038985 Treatment regimens |
| 02/06/2014 | US20140038984 Compositions and Methods for the Treatment of Metabolic and Related Disorders |
| 02/06/2014 | US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/06/2014 | US20140038971 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
| 02/06/2014 | US20140038959 Methods of treating tumors |
| 02/06/2014 | US20140038958 Cdk8-cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer |
| 02/06/2014 | US20140038956 Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc). |
| 02/06/2014 | US20140038947 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/06/2014 | US20140038943 Serotonin receptor modulator |
| 02/06/2014 | US20140038942 RORgammaT INHIBITORS |
| 02/06/2014 | US20140038935 Dihydrodiazepines useful as inhibitors of protein kinases |
| 02/06/2014 | US20140038929 Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction |
| 02/06/2014 | US20140038928 5-(2--1-hydroxyethyl-8-hydroxyquinolin-2 (1h)-one and its use in the treatment of pulmonary diseases |
| 02/06/2014 | US20140038924 Anti-Thrombotic Compounds |
| 02/06/2014 | US20140038919 Hepatitis c inhibitors and uses thereof |
| 02/06/2014 | US20140038916 O-(substituted benzyl) phosphoramidate compounds and therapeutic use |
| 02/06/2014 | US20140038914 Compounds for use in the treatment of bacterial infection |
| 02/06/2014 | US20140038889 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| 02/06/2014 | US20140038888 Pharmaceutical combinations for the treatment of metabolic disorders |
| 02/06/2014 | US20140038883 Novel azacoumarin derivatives having mdr pump inhibiting activity |
| 02/06/2014 | US20140038881 Therapeutic Peptides |
| 02/06/2014 | US20140038821 Isoxazolines for controlling invertebrate pests |
| 02/06/2014 | US20140037754 Aminopyrimidines useful as kinase inhibitors |
| 02/06/2014 | US20140037743 Microencapsulated bioactive agents for oral delivery and methods of use thereof |
| 02/06/2014 | US20140037742 Alginate microparticles and methods of using the same |
| 02/06/2014 | US20140037733 Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases |
| 02/06/2014 | US20140037727 Tablet Of Paracetamol Containing An Encapsulated Flavorant |
| 02/06/2014 | US20140037713 Transdermal compositions for anti-cholinergic agents |
| 02/06/2014 | US20140037688 Materials and Methods for Treating Conditions Associated with Pathogenic Biofilm |
| 02/06/2014 | US20140037680 Novel method |
| 02/06/2014 | US20140037666 Compositions for preventing and/or treating an infection by an hiv-1 virus |
| 02/06/2014 | US20140037654 Therapeutic method and medicament for htlv-1 associated myelopathy (ham) |
| 02/06/2014 | US20140037650 Compositions and methods related to antibodies to staphylococcal proteins isda or isdb |
| 02/06/2014 | US20140037637 Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4) |
| 02/06/2014 | US20140037635 Methods of treatment using il-17e antagonists |
| 02/06/2014 | US20140037624 Anti-fgfr4 antibodies and methods of use |
| 02/06/2014 | US20140037617 Kinase modulation, and indications therefor |
| 02/06/2014 | US20140037614 Therapeutic and prophylactic methods, uses and compositions comprising anexin a5 |
| 02/06/2014 | US20140037613 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 02/06/2014 | US20140037604 Nutritional compositions comprising alpha-hydroxyisocaproic acid |
| 02/06/2014 | US20140037603 Nutritional compositions including branched chain fatty acids for improving gut barrier function |
| 02/06/2014 | US20140037602 Nutritional compositions including branched chain fatty acids and methods of using same |
| 02/06/2014 | US20140037601 Nutritional compositions including branched chain fatty acids for wound healing |
| 02/06/2014 | US20140037584 Oncolytic rhabdovirus |
| 02/06/2014 | US20140037583 Methods and compositions suitable for preventing and treating hyperleptinemia |
| 02/06/2014 | US20140037580 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE) |